Ukraine reports 5,276 new COVID-19 cases
Zelensky: Every third Ukrainian considers road construction one of greatest achievements of 2021
Ukraine ready to implement Minsk agreements, but Russia's desire needed - Yermak
Michel: EU unanimously agree to roll over economic sanctions against Russia
Actions by Ukraine's partners will help prevent worst-case scenario - Zelensky
COVID-19 in Ukraine: Health officials confirm 8,899 daily cases as of Dec 17
Macron tells Zelensky he declared support for Ukraine in call with Putin
Zelensky, Scholz discuss gas transit through Ukraine after 2024
Ukraine ready for any format of talks with Russia - Zelensky
Ukraine’s only journalist in Russia facing extremism charges - lawyer
PM Shmyhal: First two applications for investment projects worth $96 million filed
Zelensky, PM of Italy discuss security situation around Ukraine
President signs off State Budget 2022
London considering all options for responding to Russia's aggression against Ukraine
Putin, Biden to hold another round of talks
Some 260,000 Ukrainians “victims of human trafficking” over 30 years - prosecutor general
Ukraine plans to create center to protect energy infrastructure from cyber attacks
No clear idea so far when Normandy Four top diplomats set to meet - German Ambassador
Ukraine receives EUR 600M in macro-financial assistance from EU
Zelensky holds phone conversation with PM of Israel
Ukraine sets new daily COVID vaccination record
MFA: European Union has not yet removed Ukraine from list of safe countries
Kyiv records 1,023 new COVID-19 cases, 29 deaths
G7 ambassadors welcome adoption of law on NABU status
Ukraine can increase Covid vaccination rates to 1.5M a week – Liashko
The Ministry of Health of Ukraine has permitted the start of clinical trials for Ukrainian drug intended for the treatment of coronavirus disease.
The relevant order of the Ministry of Health No.1038 of May 4 was published on the Ministry’s website.
"To permit clinical trials for a pharmaceutical product intended to implement measures aimed at preventing the occurrence and spread, localization and elimination of coronavirus disease (COVID-19)," the document reads.
According to the annex to the order, a "multicenter randomized study to evaluate the effectiveness of Bioven pharmaceutical product manufactured by the LLC Biopharma Plazma in the complex therapy of patients with pneumonia caused by coronavirus infection COVID-19 / SARS-CoV-2" will be conducted.
The trials will be conducted at Kyiv City Clinical Hospital No.17, Bila Tserkva City Hospital No. 3, Lviv Regional Infectious Diseases Clinical Hospital, Odesa City Infectious Diseases Hospital, and Kyiv City Clinical Hospital No.4.
As of May 6, Ukraine recorded 13,184 coronavirus cases, including 2,097 recoveries and 327 deaths.
Следите за нами в Facebook